active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/YWx0ZXJpdHl0aGVyYXBldXRpY3MuY29t/images/2025-04-04_icon.png
    logo_url: https://api.polygon.io/v1/reference/company-branding/YWx0ZXJpdHl0aGVyYXBldXRpY3MuY29t/images/2025-04-04_logo.png
cik: '0001131343'
composite_figi: BBG000DK9TP0
currency_name: usd
description: "Alterity Therapeutics Ltd is active in the healthcare domain. The company\
    \ is engaged in research collaborations for the treatment of Parkinsonian movement\
    \ disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative\
    \ disorders. The company's drug candidate-PBT2 is being developed for the treatment\
    \ of Alzheimer's and Huntington's diseases. It has a\_drug candidate for Parkinson's\
    \ disease and other movement disorders (ATH434). The Group operated in one segment,\
    \ being researching and developing Parkinsonian and other neurodegenerative disorders."
homepage_url: https://www.alteritytherapeutics.com
list_date: '1992-03-04'
locale: us
market: stocks
market_cap: 76089316.66
name: Alterity Therapeutics Limited American Depositary Shares
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001SHP8H6
share_class_shares_outstanding: 15345776
ticker: ATHE
ticker_root: ATHE
total_employees: 10
type: ADRC
weighted_shares_outstanding: 14803369
